Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0000843006-25-000025 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
58.36% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.22% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.64% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-21.34% · CORE · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
78.03% · CORE · VALID
Operating margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-12.36% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.39% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.71% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 69.09%
Current 58.36%
Delta -10.73% Capex Intensity Increased
Previous 0.08%
Current 0.22%
Delta 0.14% Cash Generation Decreased
Previous 13.71%
Current 13.64%
Delta -0.06% Growth Increased
Previous -30.92%
Current -21.34%
Delta 9.58% Margin Increased
Previous 75.64%
Current 78.03%
Delta 2.39% Profitability Increased
Previous -70.78%
Current -12.36%
Delta 58.41% R And D Intensity Increased
Previous 12.23%
Current 13.39%
Delta 1.15% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.